Sino Biopharm (1177.HK) Announces 2022 Annual Results

HONG KONG, Mar 31, 2023 – (ACN Newswire via – Sino Biopharmaceutical Limited (“Sino Biopharm” or the “Company”, together with its subsidiaries, the “Group”) (HKEX:1177), a leading innovation-driven pharmaceutical conglomerate in the PRC, has announced its audited financial results for the year ended 31 December 2022. Development Highlights Oncology Innovative Drugs— Focus V (Anlotinib […]

ACROMETA Signs Sales & Purchase Agreement for Additional 40% of Life Science Incubator

SINGAPORE, Mar 31, 2023 – (ACN Newswire via – ACROMETA Group Limited, an established specialist engineering service provider in the field of controlled environments serving mainly the healthcare, biotechnology, pharmaceutical, research and academia sectors, has entered into a Sales and Purchase Agreement (“the Agreement”) for an additional 40% of the outstanding shares of Life […]


HONG KONG, Mar 31, 2023 – (亞太商訊 via – 中國領先的創新研發驅動型醫藥集團—中國生物製藥有限公司(「中國生物製藥」或「公司」,連同附屬公司統稱「集團」)(股票編號:1177)公佈截至2022年12月31日止12個月之經審核財務業績。…

Fujitsu recognized as a Leader in the Gartner Magic Quadrant for Outsourced Digital Workplace Services report

TOKYO, Mar 31, 2023 – (JCN Newswire via – Fujitsu today announced that it was recognized as a Leader by Gartner in the 2023 Magic Quadrant for Outsourced Digital Workplace Services (1). From our perspective, Fujitsu’s inclusion in the report reflects its established reputation in this field and commitment to enhancing the experience for […]

Expand Investment in Science and Technology and Empower Industry Development, Legend Holdings Realized Revenue of RMB483.7 billion by 2022

HONG KONG, Mar 31, 2023 – (ACN Newswire via – Legend Holdings Corporation (stock code: 3396.HK) announced its audited annual results for the year ended December 31, 2022 (the “Reporting Period”) on March 31, 2023. During the Reporting Period, Legend Holdings achieved revenue of RMB483.7 billion and net profit attributable to equity holders of […]

HTSC reports annual revenue of RMB 46.82 billion in 2022

HONG KONG, Mar 31, 2023 – (ACN Newswire via – HTSC (stock code: 6886.HK ; “the Company”), a leading global financial services provider, is pleased to announce the Company’s annual results for the year ended December 31, 2022. — Revenue for the year was RMB 46.82 billion— Profit attributable to shareholders amounted to RMB […]

Earable Neuroscience and Excelpoint Announces Strategic Partnership to Accelerate the Commercialisation of the World’s First AI-powered Consumer Wearable, FRENZ Brainband, to Solve Global Sleep Pandemic

Since the COVID-19 pandemic began, researchers around the world have documented a surge in sleep disorders which affect overall health, safety and quality of life Invented by Earable® Neuroscience, FRENZ™ Brainband is the world’s first AI-powered consumer wearable that tracks and stimulates brain activities to enhance mental well-being through improvements in sleep, relaxation and focus […]

With Innovation-driven Quality, Sustainable Development, Wuling Motors(00305.HK)Returns to Profitability in 2022

HONG KONG, Mar 31, 2023 – (ACN Newswire via – As the global new energy automobile industry continues to experience rapid growth, there has been an acceleration in the R&D and application of new products and technologies. Technological innovation is driving the continuous upgrading of the industry. At the same time, the automotive industry […]

聯控2022年收入4,837億 穩健經營 蓄力科創

HONG KONG, Mar 31, 2023 – (亞太商訊 via – 據財華社報道,3月的國際金融市場可謂一波未平一波又起,前有矽谷銀行突然倒閉,後有百年投行瑞士信貸爆發危機被折價收購,雖然兩家機構規模不可相提並論,但暴雷原因却都離不開2022年美聯儲連續的大…

Eisai: Additional Detailed Analyses from Phase 2 Study 201 of Lecanemab Published as Three Papers in Peer-Reviewed Journals

TOKYO and CAMBRIDGE, Mass., Mar 31, 2023 – (JCN Newswire via – Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) announced today that three additional detailed analyses from the Phase IIb clinical study (Study 201), evaluating the efficacy and safety of lecanemab for mild cognitive impairment (MCI) due to Alzheimer’s disease (AD) and mild […]

Demonstration Test of “Smart Industrial Safety” by Newly Developed MHI Drone Carried Out with Chubu Electric

TOKYO, Mar 31, 2023 – (JCN Newswire via – Mitsubishi Heavy Industries, Ltd. (MHI), in collaboration with Chubu Electric Power Co., Inc. (Chubu Electric), has conducted a demonstration test of “Smart Industrial Safety,” a system that performs on-site confirmation by drone. The test, carried out in Toyota City, Aichi Prefecture, confirmed the effectiveness of […]

TANAKA Memorial Foundation Announces Recipients of Precious Metals Research Grants

TOKYO, Mar 31, 2023 – (JCN Newswire via – The TANAKA Memorial Foundation’s Representative Director, Hideya Okamoto, announced the recipients of the FY2022 Precious Metals Research Grants. Following a rigorous screening process, the Gold Awards, each for 2 million yen, were presented to Associate Professor Masashi Kaneko of Osaka University and Professor Seiji Miura […]

NEC Establishes Subsidiaries in Europe for Strengthening Global AI Drug Development Business

Tokyo (Japan), Hilversum (Netherlands), Oslo (Norway), Mannheim (Germany), Mar 31, 2023 – (JCN Newswire via – NEC Corporation (NEC) announced in 2019 that it would expand the application of its cutting-edge AI technologies to drug development, focusing on advanced therapy as part of enhancing its healthcare business. Subsequently, in order to advance AI-powered personalized […]